Johan Harmenberg
Chief Medical Officer
Pharmaceutical sciences
Oncopeptides AB (ONCO.ST)
Sweden
Biography
Johan Harmenberg, M.D., Ph.D. has served as Chief Medical Officer of Oncopeptides AB since 2012. Johan has previously held roles at a number of life sciences companies including as CEO for Axelar AB and Akinion AB, Chief Medical Officer at Algeta AB, Vice President Development for Medivir AB and Global Medical Director for Pharmacia Upjohn. He is the author of over 100 publications for a range of scientific journals. Johan holds a Ph.D. and M.D. from the Karolinska Institute in Stockholm, Sweden. He is also Associate Professor (Docent) at the same institution. He is Chairman of Gungner Medical AB, KarSar Fastigheter AB and Sarak Fastigheter AB as well as Director of Medivir AB and Chief Medical Officer of Glionova AB.
Research Interest
business and administration oncology
